Aspen’s shares plunge by a third on news of contractual dispute
Company sees R22bn wiped off its market cap
23 April 2025 - 11:15
UPDATED 23 April 2025 - 23:50
Shares in Africa’s biggest pharmaceutical manufacturer, Aspen Pharmacare, plunged by a third in intraday trade on Wednesday after it announced that a contractual dispute could slash core earnings for its 2025 financial year by as much as R2bn.
By market close the share price was down 30.71% to R112, with the fall cutting about R22bn off its market cap, which now amounts to R50bn...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.